MedTrace Logo

Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height

NCT00396474 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-04-22

No results posted yet for this study

Summary

The purpose of this study is to demonstrate that insulin sensitivity is not different between growth hormone - treated subjects who are small for gestational age (SGA) and an SGA cohort of subjects matched by gender and body mass index (BMI) who are not treated with growth hormone (GH) and who remain short at final height.

Conditions

  • Infant, Small for Gestational Age

Interventions

OTHER

post GH treatment observational study

Intravenous glucose tolerance test (IVGTT)

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Completion
2012-01-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00396474 on ClinicalTrials.gov